Novo Nordisk

Page 6 of 9

Novo Nordisk CEO Lars Fruergaard Jorgensen Interview
Retail

Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark

By Sanne Wass, Naomi Kresge and Bloomberg
May 1, 2024
Lars Fruergaard Jorgensen
Health

No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said

By Jonel Aleccia and The Associated Press
April 13, 2024
Pascal Soriot, chief executive officer of Astrazeneca Plc, arrives at the CEO council at the Great Hall of the People in Beijing, Chin
Success

Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO

By
April 10, 2024
Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
Health

Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it

By Naomi Kresge and Bloomberg
April 6, 2024
Bernie Sanders
Politics

‘Outrageous’: Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture

By Madison Muller, Robert Langreth and Bloomberg
March 28, 2024
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Health

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

By Madison Muller, Robert Langreth and Bloomberg
March 28, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk
Leadership

Ozempic maker Novo Nordisk has a new goal for its leadership team: Make sure no more than 10% of your staff are stressed

By
March 22, 2024
The foundation behind Ozempic maker Novo Nordisk is funding an Nvidia-backed AI supercomputer project
Health

The foundation behind Ozempic maker Novo Nordisk is funding an Nvidia-backed AI supercomputer project

By Chris Morris and Prarthana Prakash
March 20, 2024
Catherine Howarth, CEO of ShareAction.
Retail

Rebel investors want KitKat maker Nestlé to cut back on junk food—but the fortunes of its Mindful Chef brand suggest customers aren’t ready for a health kick

By
March 14, 2024
A person using Ozempic
Retail

Wegovy and Ozempic have ignited a gold rush in pharma as well as an upsurge in fake ‘skinny jabs’, leading to surge in hospitalizations

By Ashleigh Furlong and Bloomberg
March 13, 2024
tube of wegovy injections
Lifestyle

Novo Nordisk eclipses Tesla on positive trial results for a weight loss drug that may be more powerful than its own Wegovy 

By
March 8, 2024
62-year-old who lost 40 pounds in 9 months on Wegovy wants to stop the treadmill: ‘At some point you have to come off of them. I don’t want to be on them forever’
Health

62-year-old who lost 40 pounds in 9 months on Wegovy wants to stop the treadmill: ‘At some point you have to come off of them. I don’t want to be on them forever’

By Jonel Aleccia and The Associated Press
March 7, 2024
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity.
Retail

Novo Nordisk’s Wegovy and Ozempic boom saved Denmark’s GDP from a no-growth 2023—and will help double its expected growth this year, country’s largest bank says

By Niclas Rolander and Bloomberg
March 5, 2024
Stock traders from various companies work in five circular and one semi-circular trading floor at the Frankfurt Stock Exchange.
Finance

Meet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy

By
March 3, 2024
WHO
Health

A billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says

By Naomi Kresge, Angela Feliciano and Bloomberg
March 1, 2024

Most Popular